
News
Hong Kong stocks in the innovative drug concept sector continue to rise, with Jingtai Holdings up over 6%, Hengrui Pharma up over 5%, SIHUAN PHARM up over 4%, INNOVENT BIO and WuXi AppTec up over 3%, and BeiGene up over 2%

Hong Kong stocks in the innovative drug concept sector continue to rise, with Jingtai Holdings up over 6%, Hengrui Pharma up over 5%, SIHUAN PHARM up over 4%, INNOVENT BIO and WuXi AppTec up over 3%, and BeiGene up over 2%